Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone

American Journal of Physiology - Endocrinology and Metabolism

Volumn 271, Issue 4 34-4, 1996, Pages

  Sreenan, Seamus ^a   Sturis, Jeppe ^a   Pugh, William ^a   Burant, Charles F ^a   Polonsky, Kenneth S ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

insulin resistance; insulin secretion; non insulin dependent diabetes mellitus

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; METFORMIN; TRIACYLGLYCEROL; TROGLITAZONE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0029911348     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.271.4.e742     Document Type: Article

References (28)

1. Bailey, C. J. Metformin revisited: its actions and indications for use. Diabetic Med. 5: 315-320, 1988.
2. Beck-Nielsen, H., A. Vaag, P. Damsbo, A. Handberg, O. H. Nielsen, J. E. Henriksen, and P. Thye-Rønn. Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care 15: 418-429, 1992.
3. Clark, J. B., C. J. Palmer, and W. N. Shaw. The diabetic Zucker fatty rat. Proc. Soc. Exp. Biol Med. 173: 68-75, 1983.
4. DeFronzo, R. A. The triumvirate: β-cell, muscle and liver. A collusion responsible for NIDDM. Diabetes 37: 667-687, 1988.
5. Friedman, J. E., J. E. De Venté, R. G. Peterson, and G. L. Dohm. Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa). Am. J. Physiol. 261 (Endocrinol. Metab. 24): E782-E788, 1991.
6. Fujita, T., Y. Sugiyama, S. Taketomi, T. Sohda, Y. Kawamatsu, H. Iwatsuka, and Z. Suzuoki. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3378, U-63,287, ciglitazone), a new antidiabetic agent. Diabetes 32: 804-810, 1983.
7. Fujiwara, T., S. Yoshioka, T. Yoshioka, I. Ushiyama, and H. Horikoshi. Characterization of new oral antidiabetic agent CS-045. Studies in KK and b/ob mice and Zucker fatty rats. Diabetes 37: 1549-1558, 1988.
8. Galuska, D., L. A. Nolte, J. R. Zierath, and H. Wallberg-Henriksson. Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM. Diabetologia 37: 826-832, 1994.
9. Hughes, T. A., J. T. Gwynne, B. R. Switzer, C. Herbst, and G. White. Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus. Am. J. Med. 77: 7-17, 1984.
10. Ibrahimi, A., L. Teboul, D. Gaillard, E. Z. Amri, G. Ailhaud, P. Young, M. A. Cawthorne, and P. A. Grimaldi. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells. Mol. Pharmacol. 46: 1070-1076, 1994.
11. Jackson, R. A., M. I. Hawa, J. B. Jaspan, B. M. Sim, L. DiSilvio, D. Fetherbe, and A. B. Kurtz. Mechanism of metformin action in non-insulin dependent diabetes. Diabetes 36. 632-640, 1987.
12. Johnson, A. B., J. M. Webster, C.-F. Sum, L. Heseltine, M. Argyraki, B. G. Cooper, and R. Taylor. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. Metab. Clin. Exp. 42: 1217-1222, 1993.
13. Kraegen, E. W., D. E. James, A. B. Jenkins, D. J. Chisholm, and L. H. Storlien. A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding of rats. Metab. Clin. Exp. 38: 1089-1093, 1989.
14. Leahy, J. L., S. Bonner-Weir, and G. C. Weir. β-cell dysfunction induced by chronic hyperglycemia. Diabetes Care 15: 442-453, 1992.
15. Lee, Y., H. Hirose, M. Ohneda, J. H. Johnson, J. D. McGarry, and R. H. Unger. Beta-cell lipotoxicity in the pathogenesis of non-insulin dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc. Natl. Acad. Sci. USA 91: 10878-10882, 1994.
16. Matthaei, S., J. P. Reibold, A. Hamann, H. Benecke, H. U. Håring, H. Greten, and H. H. Klein. In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes. Endocrinology 133: 304-311, 1993.
17. Nolan, J. J., B. Ludvik, P. Beerdsen, M. Joyce, and J. Olefsky. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl. J. Med. 331: 1188-1193, 1995.
18. Ohneda, M., L. R. Inman, and R. H. Unger. Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta cell Glut-2 and glucose incompetence. Diabetologia 38. 173-179, 1995.
19. Peterson, R. G., W. N. Shaw, M. A. Neel, L. A. Little, and J. Eichberg. Zucker diabetic fatty rat as a model for non-insulin dependent diabetes mellitus. Inst. Lab. Anim. Res. News 32: 16-19, 1990.
20. Pfeifer, M. A., Halter J. B., and D. Porte, Jr. Insulin secretion in diabetes mellitus. Am. J. Med. 70: 578-588, 1981.
21. Polonsky, K. S. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research. Diabetes 44: 705-717, 1995.
22. Porte, D., Jr. β-cells in type II diabetes mellitus. Diabetes 40: 166-180, 1991.
23. Randle, P. J., C. N. Hales, P. B. Garland, and E. A. Newsholme. The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
24. Rossetti, L., R. A. DeFronzo, R. Gherzi, P. Stein, G. Andraghetti, G. Falzetti, G. Shulman, Klein-Robbenhaar, and R. Cordera. Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations. Metab. Clin. Exp. 39: 425-435, 1990.
25. Rossetti, L., A. Giaccari, and R. A. DeFronzo. Glucose toxicity. Diabetes Care 13: 610-629, 1990.
26. Schafer, G. Biguanides: a review of history, pharmacodynamics and therapy. Diabete Metab. 9: 148-163, 1983.
27. Sturis, J., W. L. Pugh, J. Tang, D.M. Ostrega, J. S. Polonsky, and K. S. Polonsky. Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat. Am. J. Physiol. 267 (Endocrinol. Metab. 30): E250-E259, 1994.
28. Widén, E. I. M., J. G. Eriksson, and L. C. Groop. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM. Diabetes 41: 354-358, 1992.